United Capital Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.3M | Sell |
48,493
-798
| -2% | -$383K | 0.13% | 141 |
|
|
2026
Q1 | $24.2M | Buy |
49,291
+593
| +1% | +$322K | 0.15% | 126 |
|
|
2025
Q4 | $28.2M | Buy |
48,698
+3,327
| +7% | +$1.88M | 0.17% | 104 |
|
|
2025
Q3 | $22M | Buy |
45,371
+19,340
| +74% | +$9M | 0.16% | 120 |
|
|
2025
Q2 | $10.6M | Sell |
26,031
-1,981
| -7% | -$828K | 0.09% | 187 |
|
|
2025
Q1 | $13.9M | Buy |
28,012
+462
| +2% | +$250K | 0.12% | 141 |
|
|
2024
Q4 | $14.3M | Sell |
27,550
-1,634
| -6% | -$898K | 0.12% | 142 |
|
|
2024
Q3 | $18.1M | Buy |
29,184
+311
| +1% | +$184K | 0.15% | 132 |
|
|
2024
Q2 | $16M | Sell |
28,873
-4,603
| -14% | -$2.64M | 0.14% | 140 |
|
|
2024
Q1 | $19.5M | Buy |
33,476
+159
| +0.5% | +$89.2K | 0.16% | 126 |
|
|
2023
Q4 | $17.7M | Sell |
33,317
-17,288
| -34% | -$8.37M | 0.15% | 139 |
|
|
2023
Q3 | $25.6M | Buy |
50,605
+399
| +0.8% | +$213K | 0.17% | 121 |
|
|
2023
Q2 | $26.2M | Sell |
50,206
-4,089
| -8% | -$2.21M | 0.14% | 130 |
|
|
2023
Q1 | $31.3M | Sell |
54,295
-2,224
| -4% | -$1.25M | 0.17% | 115 |
|
|
2022
Q4 | $31.1M | Buy |
56,519
+743
| +1% | +$394K | 0.17% | 121 |
|
|
2022
Q3 | $28.3M | Sell |
55,776
-6,157
| -10% | -$3.45M | 0.17% | 122 |
|
|
2022
Q2 | $33.6M | Buy |
61,933
+4,688
| +8% | +$2.58M | 0.18% | 114 |
|
|
2022
Q1 | $33.8M | Buy |
57,245
+280
| +0.5% | +$161K | 0.16% | 128 |
|
|
2021
Q4 | $38M | Sell |
56,965
-7,140
| -11% | -$4.46M | 0.18% | 121 |
|
|
2021
Q3 | $36.6M | Sell |
64,105
-2,071
| -3% | -$1.14M | 0.18% | 117 |
|
|
2021
Q2 | $33.4M | Sell |
66,176
-2,217
| -3% | -$1.05M | 0.17% | 127 |
|
|
2021
Q1 | $31.2M | Sell |
68,393
-2,107
| -3% | -$1.01M | 0.17% | 126 |
|
|
2020
Q4 | $32.8M | Sell |
70,500
-5,831
| -8% | -$2.73M | 0.2% | 108 |
|
|
2020
Q3 | $33.7M | Sell |
76,331
-2,207
| -3% | -$912K | 0.22% | 106 |
|
|
2020
Q2 | $28.5M | Sell |
78,538
-2,817
| -3% | -$944K | 0.21% | 108 |
|
|
2020
Q1 | $22.9M | Sell |
81,355
-15,167
| -16% | -$4.78M | 0.19% | 115 |
|
|
2019
Q4 | $31.4M | Buy |
96,522
+4,431
| +5% | +$1.34M | 0.2% | 108 |
|
|
2019
Q3 | $26.8M | Sell |
92,091
-6,891
| -7% | -$1.97M | 0.19% | 120 |
|
|
2019
Q2 | $29.1M | Sell |
98,982
-1,339
| -1% | -$369K | 0.19% | 115 |
|
|
2019
Q1 | $27.5M | Sell |
100,321
-4,169
| -4% | -$1.04M | 0.19% | 113 |
|
|
2018
Q4 | $23.4M | Sell |
104,490
-252
| -0.2% | -$59.1K | 0.19% | 115 |
|
|
2018
Q3 | $25.6M | Sell |
104,742
-2,056
| -2% | -$473K | 0.18% | 125 |
|
|
2018
Q2 | $22.1M | Sell |
106,798
-347
| -0.3% | -$73.7K | 0.16% | 135 |
|
|
2018
Q1 | $22.1M | Buy |
107,145
+3,203
| +3% | +$672K | 0.17% | 140 |
|
|
2017
Q4 | $19.9M | Sell |
103,942
-3,409
| -3% | -$653K | 0.16% | 151 |
|
|
2017
Q3 | $20.3M | Sell |
107,351
-1,214
| -1% | -$220K | 0.17% | 134 |
|
|
2017
Q2 | $18.9M | Sell |
108,565
-1,561
| -1% | -$262K | 0.17% | 132 |
|
|
2017
Q1 | $16.9M | Sell |
110,126
-2,094
| -2% | -$320K | 0.16% | 150 |
|
|
2016
Q4 | $15.8M | Sell |
112,220
-1,655
| -1% | -$244K | 0.15% | 149 |
|
|
2016
Q3 | $18.1M | Sell |
113,875
-2,107
| -2% | -$325K | 0.18% | 138 |
|
|
2016
Q2 | $17.2M | Sell |
115,982
-1,421
| -1% | -$210K | 0.17% | 128 |
|
|
2016
Q1 | $16.6M | Sell |
117,403
-5,417
| -4% | -$726K | 0.18% | 116 |
|
|
2015
Q4 | $17.4M | Sell |
122,820
-680
| -0.6% | -$90.7K | 0.2% | 102 |
|
|
2015
Q3 | $15.1M | Sell |
123,500
-8,586
| -7% | -$1.12M | 0.18% | 113 |
|
|
2015
Q2 | $17.1M | Sell |
132,086
-36,948
| -22% | -$4.82M | 0.2% | 116 |
|
|
2015
Q1 | $21.2M | Buy |
169,034
+15,534
| +10% | +$2M | 0.26% | 94 |
|
|
2014
Q4 | $19.2M | Buy |
153,500
+9,164
| +6% | +$1.11M | 0.29% | 89 |
|
|
2014
Q3 | $17.6M | Sell |
144,336
-2,541
| -2% | -$309K | 0.31% | 83 |
|
|
2014
Q2 | $17.3M | Buy |
146,877
+27,357
| +23% | +$3.22M | 0.32% | 83 |
|
|
2014
Q1 | $14.4M | Buy |
119,520
+4,587
| +4% | +$545K | 0.31% | 75 |
|
|
2013
Q4 | $12.8M | Buy |
114,933
+103,230
| +882% | +$10.3M | 0.44% | 58 |
|
|
2013
Q3 | $1.08M | Sell |
11,703
-137,874
| -92% | -$12.5M | 0.03% | 336 |
|
|
2013
Q2 | $12.7M | Buy |
+149,577
| New | +$12.5M | 0.34% | 80 |
|
Other funds holding TMO
United Capital Financial Advisors's TMO Position: Q2 2026 in Review
United Capital Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, selling an estimated $383K and leaving 48,493 shares worth $24.3M. The position accounts for 0.13% of the portfolio, ranked #141.
United Capital Financial Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $38M in Q4 2021. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- United Capital Financial Advisors held 48,493 shares of Thermo Fisher Scientific worth $24.3M as of Q2 2026.
- United Capital Financial Advisors sold 798 Thermo Fisher Scientific shares in Q2 2026, an estimated $383K.
- Thermo Fisher Scientific made up 0.13% of United Capital Financial Advisors's portfolio in Q2 2026, its #141 holding.
- United Capital Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- United Capital Financial Advisors's Thermo Fisher Scientific position peaked at $38M in Q4 2021.
- 2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.